Radix Actinidia chinensis Suppresses Renal Cell Carcinoma Progression: Network Pharmacology Prediction and In Vivo Experimental Validation

BACKGROUND: Renal cell carcinoma (RCC) is a frequent disease with limited curative methods. This study is aimed at investigating the role and mechanism of Radix Actinidia chinensis (RAC) on RCC. METHODS: The ingredients, target, and crucial pathways of RAC in RCC therapy were analyzed by network pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Biao, Zhang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356879/
https://www.ncbi.nlm.nih.gov/pubmed/35942173
http://dx.doi.org/10.1155/2022/3584445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356879/
https://www.ncbi.nlm.nih.gov/pubmed/35942173
http://dx.doi.org/10.1155/2022/3584445

Ejemplares similares